Plain-English translation of NCT06346080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand which cancer screening and diagnostic methods patients and the general public prefer for detecting stomach and esophageal cancer. This survey-based study will ask about 2,200 people worldwide what they think about different diagnostic tools and which features matter most to them when choosing one method over another.
There are several ways to screen for and diagnose stomach and esophageal cancer, but doctors don't know which methods patients actually prefer or which features are most important to people making these decisions. This study will help healthcare providers understand patient preferences and may reveal differences in what matters to people in different countries.
You likely qualify if…
You likely don't qualify if…
You would complete a one-time online survey that takes about 20–25 minutes to finish. The survey asks about your preferences for different ways to diagnose and assess stomach and esophageal cancer, and includes a few questions about your background (such as income and education level). That's it—no follow-up visits or ongoing commitments required.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Belgium
Sponsor
KU Leuven
Enrollment target
~2,200 participants
Started
August 2024
Primary completion
August 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Stijn Vanstraelen, MD
UZ Leuven
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.